Industry News Update 1/20/23

The FDA has approved a hemophilia B drug with a list price of $3.5 million, Epic will modify its system to run more easily on Apple devices, and The World Health Organization will rename monkeypox “MPOX” in an effort to destigmatize the virus.

The FDA has approved a hemophilia B drug with a list price of $3.5 million, Epic will modify its system to run more easily on Apple devices, and The World Health Organization will rename monkeypox “MPOX” in an effort to destigmatize the virus.

The FDA has approved a hemophilia B drug with a list price of $3.5 million, Epic will modify its system to run more easily on Apple devices, and The World Health Organization will rename monkeypox “MPOX” in an effort to destigmatize the virus.

The FDA has approved a hemophilia B drug with a list price of $3.5 million, Epic will modify its system to run more easily on Apple devices, and The World Health Organization will rename monkeypox “MPOX” in an effort to destigmatize the virus.

The FDA has approved a hemophilia B drug with a list price of $3.5 million, Epic will modify its system to run more easily on Apple devices, and The World Health Organization will rename monkeypox “MPOX” in an effort to destigmatize the virus.

The HHS announced it will extend the covid-19 public health emergency past January 11, 2023 & Salesforce announced Patient 360 for Health innovations for behavioral health, advanced therapy management, Salesforce Genie for healthcare, and care coordination.